Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Advanced Drug Delivery Reviews
|
December 18, 2001
Design and gene delivery activity of modified polyethylenimines
R Kircheis, L Wightman, E Wagner
Journal of Drug Targeting
|
February 22, 2000
Development of transferrin-polycation/DNA based vectors for gene delivery to melanoma cells
L Wightman, E Patzelt, E Wagner, et al.
Cytokines, Cellular & Molecular Therapy
|
July 29, 1998
Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination: IL-2, IFN-gamma, or combination IL-2 + IFN-gamma
R Kircheis, Z Küpcü, G Wallner, et al.
Bioconjugate Chemistry
|
July 19, 2001
Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery
T Blessing, M Kursa, R Holzhauser, et al.
Gene Therapy
|
September 7, 1999
PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery
M Ogris, S Brunner, S Schüller, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 8, 2001
Tumor targeting with surface-shielded ligand--polycation DNA complexes
R Kircheis, T Blessing, S Brunner, et al.
Gene Therapy
|
May 29, 2002
Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment
R Kircheis, L Wightman, M Kursa, et al.
Gene Therapy
|
April 22, 2003
Nonviral gene transfer into fetal mouse livers (a comparison between the cationic polymer PEI and naked DNA)
H Gharwan, L Wightman, R Kircheis, et al.
Cancer Gene Therapy
|
July 6, 2000
Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice
R Kircheis, Z Küpcü, G Wallner, et al.
In Vivo (Athens, Greece)
|
March 1, 1995
Early embryonic cells activate the alternative complement system
R Kircheis, L Kircheis, H Oshima, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Advanced Drug Delivery Reviews
|
December 18, 2001
Design and gene delivery activity of modified polyethylenimines
R Kircheis, L Wightman, E Wagner
Journal of Drug Targeting
|
February 22, 2000
Development of transferrin-polycation/DNA based vectors for gene delivery to melanoma cells
L Wightman, E Patzelt, E Wagner, et al.
Cytokines, Cellular & Molecular Therapy
|
July 29, 1998
Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination: IL-2, IFN-gamma, or combination IL-2 + IFN-gamma
R Kircheis, Z Küpcü, G Wallner, et al.
Bioconjugate Chemistry
|
July 19, 2001
Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery
T Blessing, M Kursa, R Holzhauser, et al.
Gene Therapy
|
September 7, 1999
PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery
M Ogris, S Brunner, S Schüller, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 8, 2001
Tumor targeting with surface-shielded ligand--polycation DNA complexes
R Kircheis, T Blessing, S Brunner, et al.
Gene Therapy
|
May 29, 2002
Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment
R Kircheis, L Wightman, M Kursa, et al.
Gene Therapy
|
April 22, 2003
Nonviral gene transfer into fetal mouse livers (a comparison between the cationic polymer PEI and naked DNA)
H Gharwan, L Wightman, R Kircheis, et al.
Cancer Gene Therapy
|
July 6, 2000
Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice
R Kircheis, Z Küpcü, G Wallner, et al.
In Vivo (Athens, Greece)
|
March 1, 1995
Early embryonic cells activate the alternative complement system
R Kircheis, L Kircheis, H Oshima, et al.
Page
of 3